North America holds a significant share of the cell lysis market due to its well-established life sciences industry, advanced laboratory infrastructure, and increasing research activities. The region benefits from strong funding for biomedical research, rising demand for molecular diagnostics, and continuous innovation in biotechnology. These factors are expected to support sustained growth of...